Merck's request to postpone the next trial over its withdrawn painkiller Vioxx was turned down Monday by a New Jersey judge. Merck had urged the judge to postpone the trial's start for 45 days, citing a "media blitz" after the first trial, which ended Aug. 19 with a Texas jury awarding $253.4 million to the widow of Bob Ernst. Set to start Sept. 12 in Atlantic City, the second trial over the drug involves a man who suffered a heart attack, but survived, four years ago, shortly after he began taking Vioxx.
August 31, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.com
Beleaguered drug maker Merck & Co.’s request to postpone the next trial over its withdrawn painkiller Vioxx was turned down Monday by the New Jersey judge presiding over the case.
Superior Court Judge Carol E. Higbee, who is overseeing nearly 2,500 Vioxx product liability cases that have been filed in New Jersey, also rejected several other Merck motions related to the upcoming trial.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
**PLEASE READ THE COMPLETE AD BEFORE APPLYING***Established 25-year boutique Plaintiff's Personal Injury Law Firm in the Dadeland area seeki...
Our client, a multi-state full-service boutique, is seeking to add a senior construction litigation associate to their Florida team. Qualif...
